Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IIIA Stage Non-small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Not applicableWithdrawnNCT01314677
What this trial is testing

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
City of Hope Medical Center
Early research (Phase 1)Active Not RecruitingNCT02503722
What this trial is testing

Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Non-Small Cell Cancer AJCC v7+3 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00020202
What this trial is testing

FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00002577
What this trial is testing

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 36
Not applicableStudy completedNCT00003566
What this trial is testing

Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 75
Testing effectiveness (Phase 2)UnknownNCT01683175
What this trial is testing

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer Stage III
Tianjin Medical University Cancer Institute and Hospital 94
Early research (Phase 1)Active Not RecruitingNCT04227028
What this trial is testing

Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell Carcinoma+7 more
City of Hope Medical Center 5
Early research (Phase 1)Study completedNCT00002519
What this trial is testing

Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 6
Large-scale testing (Phase 3)Active Not RecruitingNCT04819100
What this trial is testing

Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 152